Attitude towards genetic testing for breast cancer susceptibility: A comparison of affected and unaffected women

European Journal of Cancer Care

Volumn 19, Issue 3, 2010, Pages 360-368

  Bruno, M ^a   Digennaro, M ^a   Tommasi, S ^a   Stea, B ^a   Danese, T ^a   Schittulli, F ^a   Paradiso, A ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Breast cancer; Family health history; Genetic testing; Interest; Survey

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; BREAST TUMOR; FAMILY; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SOCIOECONOMICS; STATISTICAL MODEL;

ADULT; AGED; ATTITUDE TO HEALTH; AWARENESS; BREAST NEOPLASMS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; LOGISTIC MODELS; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 77953162428     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2009.01067.x     Document Type: Article

References (31)

1. Andrykowski MA, Munn RK, Studts JL. Interest in learning of personal genetic risk for cancer: a general population survey. Preventive Medicine 1996, 25:527-536.
2. Andrykowski MA, Lightner R, Studts JL, Munn RK. Hereditary cancer risk notification and testing: how interested is the general population? Journal of Clinical Oncology 1997, 15:2139-2148.
3. Antoniou A, Pharoah PKP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics 2003, 72:1117-1130.
4. Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B. Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiology, Biomarkers and Prevention 2000, 9:1251-1254.
5. Bottorff JL, Ratner PA, Balneaves LG, Richardson CG, McCullum M, Hack T, Chalmers K, Buxton J. Women's interest in genetic testing for breast cancer risk: the influence of socio-demographics and knowledge. Cancer Epidemiology, Biomarkers and Prevention 2002, 11:89-95.
6. Brose MS, Rebbeck DR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. Journal of the National Cancer Institute 2002, 94:1365-1372.
7. Bruno M, Tommasi S, Stea B, Quaranta M, Schittulli F, Mastropasqua A, Distante A, Di Paola L, Paradiso A. Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population. Annals of Oncology 2004, 15(1):i48-i54. Suppl.
8. Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J. Psychological and social determinants of women's decisions to undergo genetic counselling and testing for breast cancer. Clinical Genetics 1999, 55:419-430.
9. Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall WJ, Rowley PT. Women's receptivity to testing for a genetic susceptibility to breast cancer. American Journal of Public Health 1995, 85:1133-1135.
10. Donovan KA, Tucker DC. Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a socio-demographically diverse sample. Journal of Behavioral Medicine 2000, 23:15-36.
11. Geller G, Doksum T, Bernhardt BA, Metz SA. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism and family involvement on women's decisions. Cancer Epidemiology, Biomarkers and Prevention 1999, 8:377-383.
12. Gwyn K, Vernon SW, Conoley PM. Intention to pursue genetic testing for breast cancer among women due for screening mammography. Cancer Epidemiology, Biomarkers and Prevention 2003, 12:96-102.
13. Halbert HC. Decisions and outcomes of genetic testing for inherited breast cancer risk. Annals of Oncology 2004, 15(1):i35-i39. Suppl.
14. Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB. Efficacy of prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Journal of the National Cancer Institute 2001, 93:1633-1637.
15. Julian-Reynier C, Eisinger F, Vennin P, Chabal F, Aurran Y, Nogues C, Bignon YJ, Machelard-Roumagnac M, Maugard-Louboutin C, Serin D, Blanc B, Orsoni P, Sobol H. Attitudes towards cancer predictive testing and transmission of information to the family. Journal of Medical Genetics 1996, 33:731-736.
16. Kash KM, Ortega-Verdejo K, Dabney MK, Holland JC, Miller DG, Osborne MP. Psychological aspects of cancer genetics: women at high risk for breast and ovarian cancer. Seminars in Surgical Oncology 2000, 18:333-338.
17. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology 1994, 12:843-850.
18. Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. American Journal of Medical Genetics 1995, 57:385-392.
19. Lipkus IM, Iden D, Terenoire J, Feaganes JR. Relationship among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without family history of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 1999, 8:533-539.
20. Ludman EJ, Curry SJ, Hoffman E, Taplin S. Women's knoledge and attitudes about genetic testing for breast cancer susceptibility. Effective Clinical Practice 1999, 2:158-162.
21. Lynch HT, Snyder CL, Lynch JF, Riley BD, Rubinstein WS. Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist. Journal of Clinical Oncology 2003, 21:740-753.
22. Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, Seynaeve C, Tilanus-Linthorst MM, Wagner A, Dukel L, Devilee P, van den Ouweland AM, van Geel AN, Klijn JG. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000, 355:2015-2020.
23. Mogilner A, Otten M, Cunningham JD, Brower ST. Awareness and attitudes concerning BRCA gene testing. Annals of Surgical Oncology 1998, 5:607-612.
24. Narod SA. Hormonal prevention of hereditary breast cancer. Annals of the New York Academy of Sciences 2001, 952:36-43.
25. Press NA, Yasui Y, Reynolds S, Durfy SJ, Burke W. Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. American Journal of Medical Genetics 2001, 99:99-110.
26. Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. Journal of the National Cancer Institute 1999, 91:1475-1479.
27. Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N, Hensley M, Boyd J, Borgen P, Norton L, Offit K. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology 2002, 20:1260-1268.
28. Schwartz MD, Benkendorf J, Lerman C, Isaacs C, Ryan-Robertson A, Johnson L. Impact of educational print materials on knowledge, attitudes and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women. Cancer 2001, 92:932-940.
29. Smith JA, Andreopoulou E. An overview of the status of imaging screening technology for breast cancer. Annals of Oncology 2004, 15(1):i18-i26. Suppl.
30. Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiology, Biomarkers and Prevention 1995, 4:169-173.
31. Tambor ES, Rimer BK, Strigo TS. Genetic testing for breast cancer susceptibility: awareness and interest among women in general population. American Journal of Medical Genetics 1997, 68:43-49.